As col037 reports and by all accounts Viraleze sales in UK are rising exponentially (what about Hong Kong Macau must be big imo) is manufacturing keeping pace. The clinical study started in UK maybe word is getting around about the point of that study. As per CEO at AGM phase 2 of in house DEP should be starting to report finish results very soon. New omicron variant causing havoc in UK and US, China in unknown covid nightmare, reports on ABC that scientists are seeing major reduction in covid treatments effectiveness. Aztrezenica ramping up AZD 4066 in a big way, what about Merck where are they with DEP/ADC. Oh and the share price went up over 11% today. Looking pretty bright from my perspective this could be one hell of a year for Starpharma, quarterly results could be exciting. Hey Jackie any more good news to share bring it on lets get back to $1.50 asap imo
SPL Price at posting:
59.0¢ Sentiment: Buy Disclosure: Held
